Clinical Trial Update: Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

View source ↗

Summary

A clinical trial investigating autoreactive anti-Ro/SSA IgE as a biomarker to determine disease activity in Primary Sjögren's Syndrome; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Primary Sjögren's Syndrome | Status: RECRUITING